Pharmacokinetics and safety of capmatinib with food in patients with MET-dysregulated advanced solid tumors

Authors:

Abstract
No abstract available
Funding Information
  • Novartis
  • Novartis Pharmaceuticals Corporation

This publication has 40 references indexed in Scilit: